
E135: IL17 and a GLP1?
Apr 30, 2026 - 11:03
Radio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & Podcasts
Surprisingly (unbelievably?) impressive RCT evaluating the Blys/APRIL inhibitor "telitacicept" for patients with SLE (mixed SLE and SLE-LN). Very curious to see where the FDA goes with this one. Paper:
E130: Telitacicept for SLE is an episode from The Evidence Based Rheumatology Podcast by Michael Putman. Surprisingly (unbelievably?) impressive RCT evaluating the Blys/APRIL inhibitor "telitacicept" for patients with SLE (mixed SLE and SLE...
This episode belongs to The Evidence Based Rheumatology Podcast.
Use the player on this page to stream the episode online.
Published Dec 22, 2025, 13:06 long, audio available.
Surprisingly (unbelievably?) impressive RCT evaluating the Blys/APRIL inhibitor "telitacicept" for patients with SLE (mixed SLE and SLE-LN). Very curious to see where the FDA goes with this one. Paper:
You can listen to E130: Telitacicept for SLE online on Radio and Podcast. Open the player on this page to stream the available audio.
E130: Telitacicept for SLE is an episode from The Evidence Based Rheumatology Podcast by Michael Putman.
This episode is 13:06 long.
This episode was published on Dec 22, 2025.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from The Evidence Based Rheumatology Podcast when more episodes are available from the podcast feed.
You can listen to E130: Telitacicept for SLE on this page when the episode audio is available from the podcast feed.
E130: Telitacicept for SLE is from The Evidence Based Rheumatology Podcast by Michael Putman.
Published Dec 22, 2025 and 13:06 long